Crescent Biopharma, Inc.

CBIO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$34,766$41,793$47,871$90,255
Short-Term Investments$0$0$0$0
Receivables$0$176$144$1
Inventory$0$0$0$0
Other Curr. Assets$38$1,822$2,700$532
Total Curr. Assets$34,804$43,791$50,715$90,789
Property Plant & Equip (Net)$0$768$751$1,945
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$813$758$345$1,613
Total NC Assets$813$1,526$1,096$3,558
Other Assets$0$0$0$0
Total Assets$35,617$45,316$51,811$94,347
Liabilities
Payables$107$868$970$2,108
Short-Term Debt$0$742$919$1,001
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$9,507$5,226$6,992$8,715
Total Curr. Liab.$9,614$6,835$8,881$11,824
LT Debt$37,482$67$0$919
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$4,000$0$0$0
Total NC Liab.$41,482$67$0$919
Other Liabilities$0$0$0$0
Cap. Leases$0$808$919$1,920
Total Liabilities$51,096$6,902$8,881$12,743
Equity
Pref Stock$0$0$0$0
Common Stock$1$64$54$52
Retained Earnings-$17,867-$456,485-$419,586-$372,897
AOCI$0$0$0$0
Other Equity$2,387$494,835$462,461$454,448
Total Equity-$15,479$38,414$42,930$81,604
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$35,617$45,316$51,811$94,347
Net Debt$2,716-$40,984-$46,952-$88,335
Crescent Biopharma, Inc. (CBIO) Financial Statements & Key Stats | AlphaPilot